This article discusses the limitations which Brazilian hematology-oncology centers face when conducting treatment programs for Chronic Myeloid Leukemia and the problems concerning their implementation, funding and quality assessment by National Health Organization.
Leukemia Myelogenous Chronic; health planning; guideline adherence
